Brief: Polypeptide Board Recommends Shareholders Accept Samsung Offer
BRIEF-Polypeptide Board Recommends Shareholders Accept Samsung Offer Aug 31 (Reuters) - POLYPEPTIDE GROUP AG PPGN.S:
POLYPEPTIDE GROUP: SAMSUNG PEPTIDE AG PUBLISHES OFFER PROSPECTUS FOR PUBLIC TENDER OFFER FOR POLYPEPTIDE GROUP AG
BOARD UNANIMOUSLY RECOMMENDS SHAREHOLDERS ACCEPT OFFER
OFFER PRICE CHF 44.31 PER SHARE, EQUITY VALUE CHF 1.46 BILLION
OFFER PRICE REPRESENTS 40.0% PREMIUM TO LAST UNAFFECTED CLOSE, 11.6% PREMIUM TO 60-DAY VWAP
SAMSUNG PEPTIDE INTENDS TO INITIATE SQUEEZE-OUT AND DELIST POLYPEPTIDE SHARES FROM SIX
Source text: ID:nEQ6wYDqVa
Further company coverage: PPGN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on PolyPeptide AG
See all newsBrief: Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Brief: Polypeptide Group Provisional Interim Result Of The Public Tender Offer Of Samsung Biologics Co
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Samsung Biologics to launch takeover bid for PolyPeptide in September (updated)